Based in Hong Kong, we are home to some of the world’s most intrepid scientists from the world’s top university, with a proven track record of success in drug discovery and development.

In 2016, we have completed the research and development of PROHEP microbial mixture, the only innovative drug in the global microbial field that can prevent and treat HCC, and has obtained global patent technology protection.

In 2022, Prohep has made breakthrough progress in the research of non-alcoholic fatty liver disease, colorectal cancer and other fields, applying for global patent protection right now.

In 2023, Prohep has completed the formula of health care products with hypoglycemic function for diabetic patients. It is expected to be launched on the market in June 2024, with obvious blood sugar-lowering effects.

In the later stage, our products are targeting hyperlipidemia, non-alcoholic fatty liver disease, children’s anti-allergy, etc.

About Us

Zero Plus's mission is to contribute to the health and happiness of every person around the world through the pursuit of excellence in life sciences and the study of microorganisms.

Our Mission

Our vission is to discover and develop effective, safe, easy-to-use, non-toxic food supplements, medical food and drugs for the treatment of tumors, metabolic and gastrointestinal diseases.

We hope to help people recover from their pains, alleviate the pain caused by the disease, and live a better quality life despite the disease.

Zero Plus pushes forward with the quest for new possibilities for probiotics in the academic and medical fields. We work with scientists and dietitians worldwide to help people with medical conditions and find ways our probiotics can be used to help people suffering.

Our Vission 

For recent years, people have believed that gut health can reduce diseases. That was also the belief of our company's founder, Dr. Hani, who aimed to research and develop a product to benefit for all human beings.

Today, he is accredited with creating the world's first probiotic live bacteria drugs – Prohep!

Dr Hani will be contributed to move forward in the field of probiotic live bacteria drugs, leading the global live bacteria drug market and creating more promoting products.

Philosophy